Subscribe to RSS
DOI: 10.1055/s-2006-950263
Simple Methodology for the Synthesis of meso-Unsubstituted β-Substituted Alkyl Porphyrins
Publication History
Publication Date:
09 October 2006 (online)
![](https://www.thieme-connect.de/media/synlett/200617/lookinside/thumbnails/10.1055-s-2006-950263-1.jpg)
Abstract
The MacDonald [2+2]-type condensation of meso-free β-alkyldipyrromethane with different meso-free-1,9-bis(formyl)dipyrromethanes yields new asymmetric sterically unencumbered porphyrins.
Key words
β-alkylporphyrins - MacDonald condensation - disymmetric β-alkyldipyrromethane - pyrroles
-
1a
The Porphyrin Handbook
Vol. 1-10:
Kadish K.Smith KM.Guilard R. Academic Press; Boston: 2000. -
1b
The Porphyrin Handbook
Vol. 11-20:
Kadish K.Smith KM.Guilard R. Academic Press; San Diego: 2003. - 2
Ryppa C.Senge MO.Hatscher SS.Kleinpeter E.Wacker P.Schilde U.Wiehe A. Chem. Eur. J. 2005, 11: 3427 - 3
Neya S.Funasaki N. Tetrahedron Lett. 2002, 43: 1057 - 4
Neya S.Quan J.Hoshino T.Hata M.Funasaki N. Tetrahedron Lett. 2004, 45: 8629 - 5
Nguyen LT.Senge MO.Smith KM. J. Org. Chem. 1996, 61: 998 - 6
Arsenault GP.Bullock E.MacDonald SF. J. Am. Chem. Soc. 1960, 82: 4384 - 7
Chong R.Clezy PS.Liepa AJ.Nichol AW. Aust. J. Chem. 1969, 22: 229 - 8
Helms A.Heiler D.McLendon G. J. Am. Chem. Soc. 1992, 114: 6227 - 9
Young R.Chang CK. J. Am. Chem. Soc. 1985, 107: 898 - 10
Porphyrins and Metalloporphyrins
Smith KM. Elsevier; Amsterdam: 1975. - 11
Taniguchi S.Hasegawa H.Nishimura M.Takahashi H. Synlett 1999, 73
References and Notes
Selected Data
Compound 1: 1H NMR (500 MHz, CDCl3): δ = -3.94 (br s, 2 H, NH), 1.93 (t, 3 H, CH2CH
3), 3.71 (s, 3 H, CH3), 4.18 (q, 2 H, CH
2CH3), 9.46 (m, 4 H, 7,8,17,18-Hpyrrolic), 9.54 (s, 2 H, 12,13-Hpyrrolic), 10.24 (s, 1 H, α- or δ-Hmeso), 10.25 (s, 1 H, α- or δ-Hmeso), 10.33 (s, 1 H, β- or γ-Hmeso), 10.34 (s, 1 H, β- or γ-Hmeso) ppm. 13C NMR (125 MHz, CDCl3): δ = 11.45 (CH3), 17.53 (CH2
CH3), 19.78 (CH2CH3), 99.89 (Cα,δ), 104.37 (Cβ,γ), 129.00 (C12,13), 132.96 (C7,8,17,18), 142.07 (C3), 153,03 (C2) ppm. UV/vis (CH2Cl2): λmax (ε mM-1cm-1): 394 (158.9), 490 (8.1), 526 (2.8), 560 (3.7), 615 (0.5) nm. HRMS: m/z calcd for C23H21N4 [M + H]+: 353.1766; found: 353.1766.
Compound 2: 1H NMR (500 MHz, CDCl3): δ = -3.81 (br s, 2 H, NH), 1.92 (t, 6 H, CH2CH
3), 3.65 (s, 6 H, CH3), 4.12 (q, 4 H, CH
2CH3), 9.45 (dd, 4 H, Hpyrrolic), 10.11 (s, 1 H, α-Hmeso), 10.19 (s, 2 H, β,δ-Hmeso), 10.27 (s, 1 H, γ-Hmeso) ppm. 13C NMR (125 MHz, CDCl3): δ = 11.52 (CH3), 17.71 (CH2
CH3), 19.90 (CH2CH3), 95.57 (Cα), 100.19 (Cβ,δ), 104.71 (Cγ), 130.21 (C11,19), 130.50 (C12,13,17,18), 136.15 (C2,8), 142.74 (C3,7) ppm. UV/vis (CH2Cl2): λmax (ε mM-1cm-1): 393 (216.9), 491 (19.1), 523 (7.4), 560 (7.8), 613 (2.7) nm. HRMS: m/z calcd for C26H27N4 [M + H]+: 395.2236; found: 395.2243.
Compound 3: 1H NMR (500 MHz, CDCl3): δ = -3.50 (br s, 2 H, NH), 1.91 (m, 9 H, CH2CH
3), 3.64 (s, 3 H, 8-CH3), 3.69 (s, 6 H, 2,12-CH3), 4.10 (q, 2 H, 7-CH
2CH3), 4.16 (m, 4 H, 3,13-CH
2CH3), 9.43 (s, 2 H, Hpyrrolic), 10.14 (s, 1 H, α- or β-Hmeso), 10.15 (s, 1 H, α- or β-Hmeso), 10.20 (s, 1 H, δ- or γ-Hmeso), 10.21 (s, 1 H, δ- or γ-Hmeso) ppm. 13C NMR (125 MHz, CDCl3): δ = 11.51 (CH3), 17.65 (CH2
CH3), 19.85 (CH2CH3), 96.02 (Cα,β), 100.64 (Cδ,γ), 131.73 (C17,18), 133.86 (C12), 134.69 (C2), 136.73 (C8), 141.00 (C3), 141.70 (C13), 143.81 (C7) ppm. UV/vis (CH2Cl2): λmax (ε mM-1cm-1): 395 (180.7), 496 (10.5), 532 (6.7), 563 (5.5), 617 (1.9) nm. HRMS: m/z calcd for C29H33N4 [M + H]+: 437.2705; found: 437.2694.
Compound 4: 1H NMR (500 MHz, CDCl3): δ = -3.72 (br s, 2 H, NH), 1.91 (t, 12 H, CH2CH
3), 3.67 (s, 12 H, CH3), 4.13 (q, 8 H, CH
2CH3), 10.12 (s, 2 H, Hmeso), 10.13 (s, 2 H, Hmeso) ppm. 13C NMR (125 MHz, CDCl3): δ = 11.59 (CH3), 17.75 (CH2
CH3), 19.92 (CH
2
CH3), 96.29 (Cmeso), 135.03 (C2), 142.12 (C3) ppm. UV/vis (CH2Cl2): λmax (ε mM-1cm-1): 396 (162.9), 497 (12.3), 530 (8.9), 565 (6.0), 619 (4.3) nm. HRMS: m/z calcd for C39H39N4 [M + H]+: 479.3175; found: 479.3174.
Compound 6a: 1H NMR (500 MHz, CDCl3): δ = 1.06 and 1.33 (all t, 9 H, 3 CH2CH
3), 2.32 (s, 3 H, CH3), 2.45 and 4.29 (two q, 6 H, 3 CH
2CH3), 3.98 (s, 2 H, CH2), 6.04 and 7.29 (two s, 2 H, 2 Hpyrrolic), 9.60 and 10.00 (two br s, 2 H, 2 NH) ppm. 13C NMR (125 MHz, CDCl3): δ 10.55, 14.42, 15.53, 17.22, 24.67, 59.86, 60.53, 108.87, 116.26, 117.28, 122.01, 124.20, 127.02, 129.62, 134.87, 161.65, 162.50 ppm. HRMS: m/z calcd for C18H24N2O4 [M+
·]: 332.1736; found: 332.1704.
Compound 6b: 1H NMR (500 MHz, CDCl3): δ = 1.13 (t, 3 H, CH2CH
3), 2.08 (s, 3 H, CH3), 2.48 (q, 2 H, CH
2CH3), 3.94 (s, 2 H, 5-CH2), 6.04, 6.17, 6.41, 6.68 (all m, 4 H, 4 Hpyrrolic), 7.49, 7.87 (two br s, 2 H, 2 NH) ppm. 13C NMR (125 MHz, CDCl3): δ = 10.31, 16.00, 17.40, 24.51, 106.26, 108.50, 113.90, 116.99, 117.90, 121.22, 124.32, 129.21. HRMS:
m/z calcd for C12H16N2 [M+·
]: 188.1313; found: 188.1313.
Compound 6c: 1H NMR (500 MHz, CDCl3): δ = 0.91 (t, 3 H, CH2CH
3), 2.32 (s, 3 H, CH3), 2.50 (q, 2 H, CH
2CH3), 4.06 (s, 2 H, 5-CH2), 6.19, 6.91, 9.42, 9.55 (all m, 4 H, 4 Hpyrrolic), 10.99, 11.36 (two br s, 2 H, 2 NH). 13C NMR (125 MHz, CDCl3): δ = 8.86, 15.32, 16.98, 24.79, 110.37, 122.83, 125.31, 128.74, 133.23, 135.51, 138.18, 177.04, 179.04. HRMS: m/z calcd for C14H16N2O2 [M+·
]: 244.1212; found: 244.1198.